{"id":"W2052762622","doi":"10.1097/coc.0b013e3181574084","title":"Sorafenib for Metastatic Renal Cancer","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sorafenib; Rash; Internal medicine; Adverse effect; Population; Placebo; Common Terminology Criteria for Adverse Events; Oncology; Surgery; Cancer; Cohort; Gastroenterology; Hepatocellular carcinoma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002212815,0.0001274976,0.000314396,0.0001121223,0.0001908605,0.0001753985,0.0001080808,0.0001158807,0.002535956],"category_scores_gemma":[0.0004324451,0.00002725584,0.0001518151,0.0001429167,0.00008166872,0.00009406307,0.0001413344,0.0002039053,0.0003150924],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002161748,"about_ca_system_score_gemma":0.0003460292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000331841,"about_ca_topic_score_gemma":0.0007071013,"domain_scores_codex":[0.9999139,0.00003329692,0.000005700008,0.0000112854,0.00002069605,0.00001498727],"domain_scores_gemma":[0.9998482,0.0000351642,0.00004138834,0.00000615832,0.00001693106,0.00005214244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01254007,0.001563189,0.05972705,0.001533612,0.0004016946,0.003778777,0.0001634108,0.001464559,0.03372071,0.0006547657,0.02624467,0.8582076],"study_design_scores_gemma":[0.0137425,0.04328681,0.6146432,0.0004665243,0.0009466644,0.06999435,0.0002020244,0.007610287,0.03263713,0.001882196,0.2145396,0.00004870223],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.9488499,0.0426765,0.0009820744,0.001136087,0.000127117,0.0001032077,0.0002631803,0.0001185655,0.005743414],"genre_scores_gemma":[0.9916006,0.0052753,0.0007395649,0.0002408779,0.0002141246,0.00004463615,0.000342296,0.000004298591,0.001538313],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.002535956,"threshold_uncertainty_score":0.008483648,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2278800995196629,"score_gpt":0.5035995736530775,"score_spread":0.2757194741334146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}